| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 1 11-21, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
L Raptis, J Yang, H Brownell, J Lai, T Preston, MJ Corbley, RP Narsimhan and T Haliotis
Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.
To investigate the functional relationship between the transforming ability of Ras and its role as an integral component of the differentiation-promoting insulin signaling pathway, we introduced a leu61-activated ras gene into the Ras-transformable 3T3 L1 (ATCC CCL92.1) and a number of C3H10T1/2-derived preadipocytic cell lines. The results demonstrate a quantitative reciprocal regulation of differentiation and several transformation-associated properties in response to graded levels of ras gene expression, with the loss of differentiative capacity, morphological transformation, stimulation of proliferation, and anchorage-independent growth requiring increasing levels of Ras(leu61) protein. Furthermore, using novel, tightly regulatable 3T3 L1 transfectants, we demonstrated that Ras(leu61) effectiveness in blocking adipocytic differentiation is strictly dependent on the timing of its expression relative to cell growth arrest, with ras(leu61) expression being ineffective at inhibiting differentiation or inducing morphological transformation once the differentiative process has commenced. Moreover, rasleu61 induction failed to substitute for or enhance the c-Ras-dependent differentiative insulin signal, even under conditions in which it did not induce transformation. Therefore, although necessary for insulin signal transduction, the Ras signal alone is not sufficient to induce adipocytic differentiation in this system. Consistent with its established role as a downstream effector of Ras, v-Raf expression mirrored the Rasleu61 effects on adipocytic differentiation and transformation.
This article has been cited by other articles:
![]() |
A. Vultur, R. Arulanandam, J. Turkson, G. Niu, R. Jove, and L. Raptis Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen Mol. Biol. Cell, August 1, 2005; 16(8): 3832 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Hansen, R. K. Petersen, C. Jorgensen, and K. Kristiansen Deregulated MAPK Activity Prevents Adipocyte Differentiation of Fibroblasts Lacking the Retinoblastoma Protein J. Biol. Chem., July 12, 2002; 277(29): 26335 - 26339. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grammatikakis, A. Vultur, C. V. Ramana, A. Siganou, C. W. Schweinfest, D. K. Watson, and L. Raptis The Role of Hsp90N, a New Member of the Hsp90 Family, in Signal Transduction and Neoplastic Transformation J. Biol. Chem., March 1, 2002; 277(10): 8312 - 8320. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio NF-Y Mediates the Transcriptional Inhibition of the cyclin B1, cyclin B2, and cdc25C Promoters upon Induced G2 Arrest J. Biol. Chem., February 16, 2001; 276(8): 5570 - 5576. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |